MEDESIS PHARMA (EPA:ALMDP) | WebDisclosure

Basculer en Français

8300	Companies
115014	Keywords
55394	Articles
62493	Press releases

Home
Companies
MEDESIS PHARMA

ARTICLE

published on 12/20/2023 at 18:46, 11 months ago

Medesis Pharma augmente son capital pour soutenir le développement de traitements innovants
Dans un contexte de sauvegarde, Medesis Pharma lève des fonds visant à financer la recherche contre la maladie d'Alzheimer

Medesis Pharma Biotechnologie Pharmaceutique Augmentation De Capital Alzheimer Aonys®
REGULATED PRESS RELEASE

published on 12/20/2023 at 18:00, 11 months ago

MEDESIS PHARMA : Apport en trésorerie
REGULATED PRESS RELEASE

published on 10/27/2023 at 18:00, 1 year ago

MEDESIS PHARMA : RAPPORT FINANCIER SEMESTRIELS 2023
REGULATED PRESS RELEASE

published on 10/27/2023 at 18:00, 1 year ago

MEDESIS PHARMA: 2023 FIRST-HALF BUSINESS AND EARNINGS
REGULATED PRESS RELEASE

published on 10/27/2023 at 18:00, 1 year ago

MEDESIS PHARMA : ACTIVITÉS & RÉSULTATS DU 1ER SEMESTRE 2023
REGULATED PRESS RELEASE

published on 10/23/2023 at 18:00, 1 year ago

MEDESIS PHARMA PARTICIPATES IN THE 16th INTERNATIONAL CONGRESS “CLINICAL TRIALS ON ALZHEIMER DISEASE” (CTAD) IN BOSTON FROM OCTOBER 24 TO 27, 2023 AND PRESENTS A POSTER ON ITS CURRENT RESEARCH
REGULATED PRESS RELEASE

published on 10/23/2023 at 18:00, 1 year ago

MEDESIS PHARMA PARTICIPE AU 16ème CONGRÈS INTERNATIONAL « CLINICAL TRIALS ON ALZHEIMER DISEASE » (CTAD) À BOSTON DU 24 AU 27 OCTOBRE 2023 ET PRÉSENTE UN POSTER SUR SA RECHERCHE EN COURS
REGULATED PRESS RELEASE

published on 10/17/2023 at 08:00, 1 year 1 month ago

END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE TREATMENT OF ALZHEIMER’S DISEASE
REGULATED PRESS RELEASE

published on 10/17/2023 at 08:00, 1 year 1 month ago

FIN DU RECRUTEMENT DES 68 PATIENTS DANS L’ÉTUDE CLINIQUE DE PHASE 2 DE MEDESIS PHARMA SUR LE NANOLITHIUM POUR LE TRAITEMENT DE LA MALADIE D’ALZHEIMER
REGULATED PRESS RELEASE

published on 10/13/2023 at 08:45, 1 year 1 month ago

MEDESIS PHARMA : AUGMENTATION DES MOYENS ALLOUÉS AU CONTRAT DE LIQUIDITÉ CONCLU AVEC INVEST SECURITIES

Accesswire

Published on 11/21/2024 at 15:30, 31 minutes ago

CLS Health Opens New Comprehensive Care Clinic in Sugar Creek
Published on 11/21/2024 at 15:05, 56 minutes ago

"The Not-So-Secret Lives of REAL 'Mormon' Wives" - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/21/2024 at 15:00, 1 hour 1 minute ago

2-10 Home Buyers Warranty Makes Triumphant Entry Into Oklahoma Market
Published on 11/21/2024 at 15:00, 1 hour 1 minute ago

Sound Physicians’ ACO Achieves $22.9M Total Savings in 2023 Medicare Shared Savings Program
Published on 11/21/2024 at 15:00, 1 hour 1 minute ago

BlackBerry AtHoc "In Process" Finalization for FedRAMP High Authorization

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 15:41, 19 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 15:20, 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc

Les Echos

Published on 11/21/2024 at 06:58, 9 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 3 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 19 hours 54 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 20 hours 41 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE